Graybug Vision, Inc.
13Patents
13Active
13Granted
51Portfolio score
Filing activity: Sep 22, 2016 → Sep 20, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9808531B2 | Compounds and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 4 | Active |
| US11407781B2 | Equatorially modified polymer linked multimers of guanosine-3′, 5′-cyclic monophosphates | Chemistry; Metallurgy | 1 | Active |
| US9956302B2 | Compounds and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 1 | Active |
| US11160870B2 | Extended release microparticles and suspensions thereof for medical therapy | Human Necessities | 1 | Active |
| US10098965B2 | Compounds and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US10117950B2 | Compounds and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US10485876B2 | Compounds and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US10111964B2 | Compounds and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US10159747B2 | Compounds and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US10441548B2 | Aggregating microparticles for medical therapy | Human Necessities | 0 | Active |
| US11331276B2 | Aggregating microparticles for medical therapy | Human Necessities | 0 | Active |
| US11548861B2 | Drugs and compositions for the treatment of ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US11564890B2 | Aggregating microparticles for medical therapy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.